Literature DB >> 16014025

Differential distribution of the vasopressin V receptor along the rat nephron during renal ontogeny and maturation.

José M Sarmiento1, Pamela Ehrenfeld, Carolina C Añazco, Carlos E Reyes, Silvia Troncoso, Carlos D Figueroa, Werner Müller-Esterl, Carlos B González.   

Abstract

BACKGROUND: Ontogeny and cellular distribution of vasopressin receptors in the kidney are key factors determining the role of vasopressin in renal physiology. Expression of vasopressin V(2) receptor (V(2)R) mRNA and the immunoreactive protein in rat kidney were investigated.
METHODS: An antiserum directed to epitope TLD25 of the rat V(2)R sequence was characterized by Western blotting. Expression of V(2)R mRNA was assessed by reverse transcription-polymerase chain reaction (RT-PCR), and on protein level by immunohistochemistry.
RESULTS: Specificity of the antiserum was documented by Western blots from cells expressing a fusion protein of V(2)R and GFP. Using lysates of rat kidney and of native cell lines expressing V(2)R but not V(1)R, our antiserum to peptide TLD25 revealed a major band of 55 kD corresponding to the monomeric form of V(2)R, and a band of 110 kD most likely representing the homodimeric form of the receptor. This highly specific antiserum allowed us to localize the V(2)R in thick ascending limbs, distal convoluted and connecting tubules, and in collecting ducts. During ontogeny, immunoreactivity was first observed at the luminal membrane on prenatal day 20, emerging at the basolateral side from postnatal day 5 on. RT-PCR demonstrated V(2)R transcripts from prenatal day 18 to gradually increasing thereafter.
CONCLUSION: Expression of V(2)R is first detectable in the late embryonic stage of rat ontogeny starting from day E18 and gradually increasing with kidney maturation. In the adult kidney, V(2)R is differentially distributed in the various nephron segments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014025     DOI: 10.1111/j.1523-1755.2005.00426.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Renal cell markers: lighthouses for managing renal diseases.

Authors:  Shivangi Agarwal; Yashwanth R Sudhini; Onur K Polat; Jochen Reiser; Mehmet M Altintas
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-11

2.  Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum.

Authors:  Karina J Vargas; José M Sarmiento; Pamela Ehrenfeld; Carolina C Añazco; Carolina I Villanueva; Pamela L Carmona; Marianne Brenet; Javier Navarro; Werner Müller-Esterl; Carlos B González
Journal:  Differentiation       Date:  2009-01-20       Impact factor: 3.880

3.  Genetic ablation of aquaporin-2 in the mouse connecting tubules results in defective renal water handling.

Authors:  Marleen L A Kortenoeven; Nis Borbye Pedersen; R Lance Miller; Aleksandra Rojek; Robert A Fenton
Journal:  J Physiol       Date:  2013-01-28       Impact factor: 5.182

4.  Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways.

Authors:  Lida Q Fuentes; Carlos E Reyes; José M Sarmiento; Carolina I Villanueva; Carlos D Figueroa; Javier Navarro; Carlos B González
Journal:  Cell Signal       Date:  2008-05-25       Impact factor: 4.315

5.  Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC.

Authors:  Timo Rieg; Tong Tang; Shinichi Uchida; H Kirk Hammond; Robert A Fenton; Volker Vallon
Journal:  Am J Pathol       Date:  2012-11-01       Impact factor: 4.307

6.  The role of proximal nephron in cyclophosphamide-induced water retention: preliminary data.

Authors:  Sua Kim; Chor Ho Jo; Joon-Sung Park; Ho Jae Han; Gheun-Ho Kim
Journal:  Electrolyte Blood Press       Date:  2011-06-30

7.  Generation and phenotypic characterization of Pde1a mutant mice.

Authors:  Xiaofang Wang; Satsuki Yamada; Wells B LaRiviere; Hong Ye; Jason L Bakeberg; María V Irazabal; Fouad T Chebib; Jan van Deursen; Peter C Harris; Caroline R Sussman; Atta Behfar; Christopher J Ward; Vicente E Torres
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

8.  Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.

Authors:  Sonali Sinha; Nidhi Dwivedi; Shixin Tao; Abeda Jamadar; Vijayakumar R Kakade; Maura O' Neil; Robert H Weiss; Jonathan Enders; James P Calvet; Sufi M Thomas; Reena Rao
Journal:  Oncogene       Date:  2019-10-15       Impact factor: 9.867

Review 9.  The Kidney in Bardet-Biedl Syndrome: Possible Pathogenesis of Urine Concentrating Defect.

Authors:  Miriam Zacchia; Valentina Di Iorio; Francesco Trepiccione; Marianna Caterino; Giovambattista Capasso
Journal:  Kidney Dis (Basel)       Date:  2017-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.